Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. | Two biotechs are teaming up to deliver ...

AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...

The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...

Merck & Co. has picked up options on two Evaxion vaccine candidates, paying $3.2 million and dangling more than $1 billion in ...

On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with ...

In July, Biogen and Sage reported the failure of GABAA receptor positive allosteric modulator SAGE-324, also called BIIB124, ...

Enanta Pharmaceuticals has linked its respiratory syncytial virus (RSV) antiviral to significant reductions in viral load and ...

Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...

Amid the genetic medicines arms race, Flagship Pioneering is unveiling a new company to help biotechs fine-tune the precision ...